1. Home
  2. RVMD vs NTR Comparison

RVMD vs NTR Comparison

Compare RVMD & NTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$187.35

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Logo Nutrien Ltd.

NTR

Nutrien Ltd.

HOLD

Current Price

$65.34

Market Cap

34.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
NTR
Founded
2014
2017
Country
United States
Canada
Employees
883
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Agricultural Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
30.1B
34.2B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
RVMD
NTR
Price
$187.35
$65.34
Analyst Decision
Strong Buy
Buy
Analyst Count
19
22
Target Price
$140.84
$75.45
AVG Volume (30 Days)
2.8M
3.0M
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
2.95%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$4.03
Revenue Next Year
$533.02
N/A
P/E Ratio
N/A
$18.99
Revenue Growth
N/A
N/A
52 Week Low
$34.00
$53.03
52 Week High
$193.83
$85.36

Technical Indicators

Market Signals
Indicator
RVMD
NTR
Relative Strength Index (RSI) 66.86 49.96
Support Level $93.39 $58.83
Resistance Level N/A $73.31
Average True Range (ATR) 7.33 1.39
MACD 0.42 0.63
Stochastic Oscillator 79.87 75.32

Price Performance

Historical Comparison
RVMD
NTR

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About NTR Nutrien Ltd.

Created in 2018 as a result of the merger between PotashCorp and Agrium, Nutrien is the world's largest fertilizer producer by capacity. Nutrien produces the three main crop nutrients—nitrogen, potash, and phosphate—although its main focus is potash, where it is the global leader in installed capacity with a roughly 20% market share. The company is also the largest agricultural retailer in North America and Australia, selling fertilizers, crop chemicals, seeds, and services directly to farm customers through its brick-and-mortar stores and online platforms.

Share on Social Networks: